Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2000 | 06-2000 | 03-2000 | 12-1999 | 09-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,520 | 4,620 | 560 | 260 | 8,010 |
| Marketable Securities | 20,170 | 17,780 | 15,120 | 14,690 | 10,320 |
| Other current assets | 360 | 420 | 440 | 600 | 260 |
| TOTAL | $22,050 | $22,820 | $16,120 | $15,550 | $18,590 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 190 | 190 | 190 | 510 | 3,950 |
| TOTAL | $190 | $190 | $190 | $510 | $3,950 |
| Total Assets | $22,290 | $23,060 | $16,350 | $16,070 | $22,560 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,970 | 1,480 | 2,350 | 1,800 | 1,690 |
| TOTAL | $1,970 | $1,480 | $2,350 | $1,800 | $1,690 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 4,640 | 4,330 |
| TOTAL | $N/A | $N/A | $N/A | $4,640 | $4,330 |
| Total Liabilities | $1,970 | $1,480 | $2,350 | $6,450 | $6,030 |
| Shareholders' Equity | |||||
| Common Shares | 200 | 200 | 180 | 160 | 150 |
| Retained earnings | -63,320 | -60,400 | -57,070 | 0 | -47,950 |
| Other shareholders' equity | -220 | -410 | -430 | -53,630 | 3,450 |
| TOTAL | $20,320 | $21,580 | $14,000 | $9,620 | $16,520 |
| Total Liabilities And Equity | $22,290 | $23,060 | $16,350 | $16,070 | $22,550 |